Shares of Galapagos NV (NASDAQ:GLPG) gapped up prior to trading on Thursday . The stock had previously closed at $51.90, but opened at $52.47. Galapagos NV shares last traded at $54.57, with a volume of 25,543 shares changing hands.

Several analysts have issued reports on GLPG shares. Zacks Investment Research downgraded Galapagos NV from a “buy” rating to a “hold” rating in a research note on Monday, July 4th. Credit Suisse Group AG reaffirmed a “hold” rating and issued a $48.00 target price on shares of Galapagos NV in a research report on Friday, June 17th. Morgan Stanley lowered their target price on Galapagos NV from $92.00 to $89.00 and set an “overweight” rating on the stock in a research report on Monday, May 2nd. Finally, Cowen and Company reaffirmed a “buy” rating on shares of Galapagos NV in a research report on Saturday, April 30th. Two research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Galapagos NV has a consensus rating of “Buy” and an average price target of €65.50 ($72.78).

The stock’s 50 day moving average price is $53.55 and its 200-day moving average price is $48.82. The company’s market cap is $2.48 billion.

Galapagos NV is a Belgium-based biotechnology company. The Company’s activities are divided into two operating divisions: Research and Development (R & D) and Services. The R & D division is engaged in the discovery and development of small molecules. The Services division, offers target-to-drug discovery products and services to pharmaceutical and biotechnology companies and to patient foundations, encompassing target discovery and validation, screening and drug discovery through to delivery of pre-clinical candidates.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.